You are not logged in!
Do you want to login? It's free!

Tue, 2 September 2014.
Check the latest stories & news.

Search implu: Advanced

Who do you implu?    Create a Free Account!

Attachment 1

Attachment 2

WebFilings | EDGAR view
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
 
Washington, DC 20549
_____________________________________________________________________
 
 
FORM 8-K
 
CURRENT REPORT
 
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934 
______________________________________________________________________
 
Date of Report (Date of earliest event reported): January 7, 2011
 
BOSTON SCIENTIFIC CORPORATION
(Exact name of registrant as specified in charter)
 
DELAWARE
1-11083
04-2695240
(State or other
(Commission
(IRS employer
jurisdiction of
file number)
identification no.)
incorporation)
 
 
 
One Boston Scientific Place, Natick, Massachusetts
01760-1537
(Address of principal executive offices)
(Zip code)
 
Registrant's telephone number, including area code:   (508) 650-8000
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 

 

 

Item 5.02    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
 
On January 7, 2011, upon the recommendation of the Executive Compensation and Human Resources Committee, our Board of Directors approved an amendment to the Company's 2011 Performance Incentive Plan (the “2011 PIP”) changing the date an employee must remain employed with the Company to be eligible for payments under the 2011 PIP from December 31, 2011 to the date payments are made under the 2011 PIP. Payments to be made under the 2011 PIP, if any, will be made by March 15, 2012 for payments in the United States and as soon as administratively possible following December 31, 2011 for payments outside the United States. The 2011 PIP is effective for the performance period January 1, 2011 through December 31, 2011.
 
A copy of the 2011 PIP, as amended, is filed as Exhibit 10.1 hereto and incorporated herein by reference.
 
Item 9.01    Financial Statements and Exhibits
 
(d)    Exhibits (# compensatory plans or arrangements)
 
Exhibit No.
 
Description
 
 
 
10.1
 
Boston Scientific Corporation 2011 Performance Incentive Plan, as amended, effective as of January 1, 2011. #
 
 
 
 
 
 
 
 

 

 

SIGNATURE
 
 
Pursuant to the requirements of the Securities and Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
                        
                                
Date: January 13, 2011
BOSTON SCIENTIFIC CORPORATION
 
 
 
 
 
 
By:
/s/ Timothy A. Pratt
 
 
 
Timothy A. Pratt
 
 
 
Executive Vice President, Chief Administrative
 
 
 
Officer, General Counsel and Secretary
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 

 

INDEX TO EXHIBITS
 
 
Exhibit No.
 
Description
 
 
 
10.1
 
Boston Scientific Corporation 2011 Performance Incentive Plan, as amended, effective as of January 1, 2011.